Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort

C. Tcherakian, O. Brugiere, R. Kessler, M. Reynaud-Gaubert, F. Philit, V. Boussaud, C. Pison, M. Stern (Suresnes, Paris, Strasbourg, Marseille, Lyon, Grenoble, France)

Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Session: New clinical and experimental insights in lung transplantation
Session type: Thematic Poster Session
Number: 4848
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Tcherakian, O. Brugiere, R. Kessler, M. Reynaud-Gaubert, F. Philit, V. Boussaud, C. Pison, M. Stern (Suresnes, Paris, Strasbourg, Marseille, Lyon, Grenoble, France). Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort. Eur Respir J 2010; 36: Suppl. 54, 4848

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late pulmonary complications after haematopoietic stem cell transplantation (HSCT) in children: incidence and risk factors
Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects
Year: 2008



Pulmonary mycobacterial infection in allogeneic hematopoietic stem cell transplanted (HSCT) patients: A study of 7 cases
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011

Pulmonary function in very long-term survivors after allogeneic stem cell transplantation (aSCT)
Source: International Congress 2018 – New insights in testing lung and respiratory muscle functions
Year: 2018




Utility of bronchoscopy in hematopoietic stem cell transplant (HSCT) patients with pulmonary infiltrates: A prospective study.
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021


Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016


Peripheral airway function at 12 months post allogeneic haematopoietic stem cell transplantation (allo-HSCT)
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016

Determinants of cardiorespiratory fitness in young long-term survivors of hematopoietic stem cell transplantation (HSCT)
Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases
Year: 2019



Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation
Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017
Year: 2018



Small airways function in allogeneic hematopoietic stem cell transplant recipients worsens over time and is correlated with change in chronic GVHD grade
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011

Noninfectious pulmonary complications of haematopoietic stem cell transplantation
Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019
Year: 2020



Lung transplantation after allogeneic stem cell transplantation: a pan-European experience
Source: Eur Respir J, 51 (2) 1701330; 10.1183/13993003.01330-2017
Year: 2018



Airway distensibility with lung inflation following allogeneic haematopoietic stem-cell transplantation (HSCT)
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012


Lung transplantation (LTx) for fibrotic diseases: a single centre experience
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005

Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant
Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017
Year: 2018



Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003

Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease
Year: 2016


Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Source: Eur Respir J 2004; 23: 440-445
Year: 2004



Uncontrolled non-heart-beating donors vs. brain dead donors in lung transplantation: Comparison of early and late results
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016